QA: Acer Therapeutics Inc. in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001069308_2017_Acer_Therapeutics_Inc.pdf

Logs

warning Ignoring company because Expenses is zero pre-agg {'balance_sheet': {'company_id': '0001069308', 'EntityCommonStockSharesOutstanding': 7657332, 'Assets': 3866514, 'AssetsCurrent': 3816514, 'CostOfGoodsAndServicesSold': 0, 'Expenses': 0, 'IntangibleAssetsNetIncludingGoodwill': 0, 'Liabilities': 1160488, 'LiabilitiesAndStockholdersEquity': 3866514, 'LiabilitiesCurrent': 1160488, 'LiabilitiesNoncurrent': 0, 'NetIncome': -7980114, 'PropertyPlantAndEquipmentNet': 50000, 'ResearchAndDevelopmentExpense': 0, 'Revenues': 0, 'SellingGeneralAndAdministrativeExpense': 0, 'remainder_Assets': 0, 'remainder_ComprehensiveNetIncome': 0, 'remainder_Expenses': 0, 'remainder_Liabilities': 0, 'remainder_LiabilitiesAndStockholdersEquity': 2706026, 'remainder_NetIncome': -7980114, 'remainder_Revenues': 0, 'obs_EconomicCapitalRatio': nan}}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001069308')"}

Edgar->Model Mapping